Advances in leishmaniasis chemotherapy and new relevant patents

Author： Piñero Jose E   Jiménez Ignacio A   Valladares Basilio   Ravelo Ángel G  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.8, 2004-08, pp. : 1113-1123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malaria and Leishmaniasis: Current Status of Chemotherapy, New Leads and Targets for Drug Discovery

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 3, 2009-07 ,pp. : 226-267

Bentham Science Publishers

Access to resources Recommend Favorite

New Advances in Anti-HSV Chemotherapy

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 900-911

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy of Leishmaniasis: Past, Present and Future

By  

Current Medicinal Chemistry, Vol. 14, Iss. 10, 2007-04 ,pp. : 1153-1169

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Antimalarial Compounds and their Patents

By  

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 759-773

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis

By  

Current Drug Targets, Vol. 18, Iss. 14, 2017-10 ,pp. : 1598-1621

Bentham Science Publishers

Access to resources Recommend Favorite